Medicine and Dentistry
Mohs Surgery
97%
Neoplasm
71%
Surgeon
61%
Dermatology
59%
Non Melanoma Skin Cancer
51%
Skin Surgery
45%
Melanoma
39%
Cosmetics
34%
Basal-Cell Carcinoma
34%
Skin Cancer
34%
Pooled Analysis
25%
Cancer
24%
Dermatological Agent
24%
Squamous Cell Carcinoma
22%
Skin Carcinoma
21%
Clinical Examination
20%
Biopsy Technique
19%
Wound
19%
Retrospective Cohort Study
18%
COVID-19
17%
Metastatic Melanoma
17%
Microcystic Adnexal Carcinoma
17%
Vulva
17%
Melanocortin 1 Receptor
17%
Receptor Gene
17%
Pruritus
17%
Scalp
17%
Adolescence
17%
Odds Ratio
16%
Surgery
16%
Immunotherapy
15%
Health Care Cost
15%
Retrospective Study
13%
Malignant Neoplasm
12%
Confocal Microscopy
12%
Cohort Analysis
12%
Systematic Review
11%
Cancer Surgery
10%
Electrodesiccation and Curettage
10%
Atopic Dermatitis
10%
Cross Sectional Study
10%
Pembrolizumab
10%
Melanoma Skin Cancer
9%
Patient Care
9%
Neck
9%
Radiation Therapy
8%
Transplantation
8%
Clinical Research
8%
Curette
8%
Autoantibodies
8%
Keyphrases
Mohs Micrographic Surgery
100%
Dermatologic Surgery
45%
Non-melanoma Skin Cancer
43%
Surgeons
37%
Basal Cell Carcinoma
36%
Melanoma
34%
Tumor
31%
Retrospective Review
28%
Dermatologist
26%
Metastatic Melanoma
25%
Pooled Analysis
25%
Melanocortin 1 Receptor (MC1R)
21%
Cosmetic Dermatology
21%
Skin Cancer
21%
Cutaneous Squamous Cell Carcinoma (cSCC)
21%
Squamous Cell Carcinoma (SqCC)
20%
Atopic Dermatitis
20%
Clinical Examination
20%
Metastasis
18%
Mohs Surgeons
17%
Solid Organ Transplant Recipients
17%
COVID-19
17%
Evidence-based Clinical Practice Guideline
17%
Uveal Melanoma
17%
Clinical Characteristics
17%
Imaging Technology
17%
Microcystic Adnexal Carcinoma
17%
Gene Variants
17%
American Colleges
14%
Vulva
14%
Vulvar Squamous Cell Carcinoma
14%
Malignant Melanoma
14%
Cancer Inpatients
12%
Confocal Microscopy
12%
Odds Ratio
12%
Melanoma Risk
12%
Epidemiology
12%
Tissue Sparing
11%
Electrodesiccation
11%
Curettage
11%
Sun Protection
11%
Itch
11%
Clinical Practice
11%
Retrospective Cohort Study
10%
Clinical Features
10%
Skin Cancer Prevention
10%
University of Washington
10%
Patient Care
10%
Pembrolizumab
10%
Malignancy
9%